.
BioEnterprise

Abeona Therapeutics Raises $8.5 Million

Abeona Therapeutics, a Cleveland developer of therapies for rare genetic diseases, raised $8.5 million from Soros Fund Management, Perceptive Life Science Fund, and two Members of the company’s Board. Funds will be used to further develop Abeona’s rare disease programs.

Read More  >